Pfizer says its vaccine is 90.7% effective in children between 5 and 11 years old

The pharmaceutical company Pfizer assured this Friday that its vaccine against COVID-19 it is effective in 90.7% in children aged between 5 and 11 years.

SIGHT: COVID-19 | Pfizer’s vaccine is 93% effective in adolescents

In a document released on the occasion of a meeting scheduled for next week with the U.S. Food and Drug Administration (FDA), the company explained that

Three of the minors who had been inoculated with the vaccine were infected, compared to 16 who contracted the disease in the group of children who had received a placebo. versus those who were injected with the placebo.

SIGHT: AY4.2 | The WHO already monitors the new lineage of the Delta variant detected in the United Kingdom

On October 7, Pfizer and BioNtech requested the FDA authorization for the emergency use of their vaccine against

So far, the FDA only authorizes the use of this vaccine from the age of 12.

Before presenting their authorization, the pharmaceutical companies Pfizer and BioNTech announced that the results of the latest clinical tests and that the vaccine is safe, which would bring closer the possibility of an infantile serum available by the end of October or beginning of November.

• AY4.2 | The WHO already monitors the new lineage of the Delta variant detected in the United Kingdom
• COVID-19 | Coronavirus is best transmitted with low temperatures and humidity, according to study
• PAHO seeks to develop test that simultaneously detects COVID-19 and flu
• Study classifies COVID-19 as a seasonal low-temperature infection
• COVID-19 | Pharmaceutical companies and rich countries send only a seventh of promised vaccines to poor countries
• COVID-19 | Pfizer’s vaccine is 93% effective in adolescents
• Delta Plus: the new coronavirus mutation causing a growing number of infections in the UK
• COVID-19 vaccine | Third dose of Pfizer / BioNTech is 95.6% effective
• COVID-19 | FDA approves Moderna and J&J booster doses and combined use of vaccines
• COVID-19: What is known about the combination of Pfizer with the vaccines from Sinopharm, J&J and AstraZeneca?
• Following Digemid alert on Pfizer vaccine: what is myocarditis and pericarditis?
• COVID-19 vaccine: pregnant women depend more on the second dose to achieve full immunity
• What is known about the new offspring of the newly discovered Delta variant of the coronavirus?
• COVID-19 | Peru exceeded 50% of the target population vaccinated: what other countries achieved it?
• COVID-19 | What makes Peruvians decide to get vaccinated (and what doesn’t)?

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Deshawn